07:49:44 EDT Sun 07 Jun 2026
Enter Symbol
or Name
USA
CA



News last 24 hour(s) - 13 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-06-07 07:33U:PDPTFNews ReleasePUDO Inc announces earnings call for FY 2026 year end results
2026-06-06 21:50U:ELEKNews ReleaseMillionaires, Billionaires, Microcap and Penny Stock Investors - This Is Your Time To Shine
2026-06-06 21:25U:ELEKNews ReleaseMillionaires, Billionaires, Institutional, Microcap & Penny Stock Investors - Your Opportunity To Own a Stake in Elektros Inc.'s Lithium Mining, Rare Earth Minerals & EV Patent Technology at Today's Ground-Floor Value
2026-06-06 21:15U:ELEKNews ReleaseMillionaires, Billionaires, Institutional Investors, Microcap Investors, Penny Stock Investors - This Is Your Time To Shine
2026-06-06 21:05U:ELEKNews ReleaseMicrocap, Penny Stock, and Institutional Investors Across the Globe Are Discovering a Unique Opportunity in Elektros Inc.
2026-06-06 19:05U:DUKNews ReleaseDuke Energy offers tips to save energy and money as temperatures rise in the Carolinas
2026-06-06 17:00U:SENSNews ReleaseReal-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems
2026-06-06 16:45U:CORTNews ReleaseCorcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym(TM)
2026-06-06 14:45U:DXCMNews ReleaseDexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
2026-06-06 14:30U:LLYNews ReleaseLilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications
2026-06-06 09:52U:AGAENews ReleaseAll In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration
2026-06-06 09:00U:PFENews ReleaseRobust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide
2026-06-06 09:00U:ABTNews ReleaseNew Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis